JohnWOstrominskiMD

Cardiology • Boston, MA

Preventive Cardiology

Brigham and Women’s Hospital - Fellow in Cardiovascular Medicine (PGY-5)

Join to view full profile

Dr. Ostrominski is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ostrominski's full profile

Already have an account?

Office
Brigham and Women’s Hospital
Boston, MA 02115
Is this information wrong?

Education & Training

Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2021 - 2026
Brigham and Women’s HospitalFellowship, Obesity Medicine, 2023 - 2024
West Roxbury Veterans Affairs Medical CenterChief Resident, 2021 - 2021
Brigham and Women's HospitalResidency, Internal Medicine, 2018 - 2021
The University of Texas Health Science Center at San AntonioClass of 2017
Harvard Medical SchoolFellowship, Clinical

Certifications & Licensure

MA State Medical License 2018 - 2024
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020.
Rahul Aggarwal, John W Ostrominski, Muthiah Vaduganathan> ;JAMA. 2024 May 8
Contemporary American and European Guidelines for Heart Failure Management: JACC: Heart Failure Guideline Comparison.
Ralph J Riello 3rd, John W Ostrominski, Ersilia M DeFilippis, Kannu Bansal, Biykem Bozkurt, Paul A Heidenreich, Muthiah Vaduganathan> ;JACC. Heart Failure. 2024 May 1
Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease.
Ostrominski, J., Powell-Wiley, T.> ;Current Atherosclerosis Reports. 2024 Jan 1
Aspirin and diabetes prevention among healthy older adults-practice-changing or hypothesis-generating?
John W Ostrominski, Vanita R Aroda> ;The Lancet. Diabetes & Endocrinology. 2024 Feb 1
Glucagon-Like Peptide-1 Receptor Agonists in Heart Failure: STEPping Across the Ejection Fraction Divide.
Muthiah Vaduganathan, John W Ostrominski> ;Journal of the American College of Cardiology. 2023 Nov 28
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial.
John W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian L Claggett, Zi Michael Miao, Akshay S Desai, Pardeep S Jhund, Mikhail N Kosiborod, Carolyn S P Lam, S...> ;Circulation. 2023 Dec 12
Pulmonary embolism with thrombus-in-transit across a patent foramen ovale.
John W Ostrominski, Christine J Wang, Umberto Campia, Jean M Connors, Dirk J Varelmann, Domagoj Mladinov, Mohamed Keshk, Hicham Skali> ;Lancet. 2023 Sep 30
4 citations
Prevalence and Overlap of Cardiac, Renal, and Metabolic Conditions in US Adults, 1999-2020.
John W Ostrominski, Suzanne V Arnold, Javed Butler, Gregg C Fonarow, Jamie S Hirsch, Swetha R Palli, Bonnie M K Donato, Christina M Parrinello, Thomas O'Connell, Eric ...> ;JAMA Cardiology. 2023 Nov 1
2 citations
Cardiac Myosin Inhibitors for Managing Obstructive Hypertrophic Cardiomyopathy: JACC: Heart Failure State-of-the-Art Review.
John W Ostrominski, Ruby Guo, Perry M Elliott, Carolyn Y Ho> ;JACC. Heart Failure. 2023 Jul 1
1 citations
Defining the optimal approach to revascularization in chronic coronary syndrome patients with diabetes and multivessel disease: Is our equipoise evidence-based?
John W Ostrominski, William E Boden> ;International Journal of Cardiology. Heart & Vasculature. 2023 Jun 1
3 citations
Cardio-Renal-Metabolic Overlap, Outcomes, and Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction.
John W Ostrominski, Jorge Thierer, Brian L Claggett, Zi Michael Miao, Akshay S Desai, Pardeep S Jhund, Mikhail N Kosiborod, Carolyn S P Lam, Silvio E Inzucchi, Felipe ...> ;JACC. Heart Failure. 2023 Nov 1
Duration of Heart Failure With Preserved Ejection Fraction and Outcomes With Sacubitril/Valsartan: Insights From the PARAGON-HF Trial.
John W Ostrominski, Brian L Claggett, Milton Packer, Marc A Pfeffer, Carolyn S P Lam, Michael R Zile, Akshay S Desai, Pardeep S Jhund, Martin Lefkowitz, John J V McMur...> ;Journal of Cardiac Failure. 2023 Nov 1
1 citations
Chapter 2: Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection Fraction.
John W Ostrominski, Muthiah Vaduganathan> ;The American Journal of Medicine. 2024 Feb 1
17 citations
Virtual Care Team Guided Management of Patients With Heart Failure During Hospitalization.
Ankeet S Bhatt, Anubodh S Varshney, Alea Moscone, Brian L Claggett, Zi Michael Miao, Safia Chatur, Mathew S Lopes, John W Ostrominski, Maria A Pabon, Ozan Unlu, Xiaowe...> ;Journal of the American College of Cardiology. 2023 May 2
A Rocky Resurgence.
John W Ostrominski, Thomas E Clancy, Lynn Bry, Bruce D Levy, Joseph Loscalzo> ;The New England Journal of Medicine. 2023 Mar 2
Pulling Out All the Stops: A Case of Progressive Dyspnea.
John W Ostrominski, Deepak L Bhatt, Benjamin M Scirica> ;Circulation. 2023 Feb 21
A Shear Decline.
Marla Lipsyc-Sharf, Nathan T Connell, John W Ostrominski, Bruce D Levy, Joseph Loscalzo> ;The New England Journal of Medicine. 2022 Nov 3
13 citations
Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
John W Ostrominski, Muthiah Vaduganathan, Brian L Claggett, Rudolf A de Boer, Akshay S Desai, Dan Dobreanu, Adrian F Hernandez, Silvio E Inzucchi, Pardeep S Jhund, Mik...> ;European Journal of Heart Failure. 2022 Oct 1
4 citations
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction.
John W Ostrominski, Muthiah Vaduganathan> ;Clinical Cardiology. 2022 Jun 1
Missed Opportunities for Screening and Management of Dysglycemia among Patients Presenting with Acute Myocardial Infarction in North India: The Prospective NORIN STEMI...
John W Ostrominski, Muthiah Vaduganathan, Meennahalli Palleda Girish, Puneet Gupta, Michael J Hendrickson, Arman Qamar, Sameer Arora, Ambarish Pandey, Ankit Bansal, Vi...> ;Global Heart. 2022 Jan 1
13 citations
Cost and Value in Contemporary Heart Failure Clinical Guidance Documents
John W. Ostrominski, Sameer A. Hirji, Ankeet S. Bhatt, Javed Butler, Mona Fiuzat, Gregg C. Fonarow, Paul A. Heidenreich, James L. Januzzi, Carolyn S.P. Lam, Thomas M. ...> ;JACC. Heart Failure. 2021 May 27
1 citations
Beneath the Surface: Massive Retroperitoneal Liposarcoma Masquerading as Meralgia Paresthetica.
John W. Ostrominski, Qin Huang, Yelena Kamenker-Orlov> ;Federal Practitioner. 2021 May 1
5 citations
Coding Variation and Adherence to Methodological Standards in Cardiac Research Using the National Inpatient Sample.
John W. Ostrominski, Javier Amione-Guerra, Brian Hernandez, Joel E. Michalek, Anand Prasad> ;Frontiers in Cardiovascular Medicine. 2021 Jan 1
4 citations
Citizenship Status and Cardiothoracic Organ Transplantation in the United States.
Lauren Sinnenberg, Sara R. Machado, John W. Ostrominski, Josef Stehlik, Mandeep R. Mehra, Muthiah Vaduganathan> ;Circulation. Heart Failure. 2020 Nov 9
8 citations
CRISPR/Cas9-mediated introduction of the sodium/iodide symporter gene enables noninvasive in vivo tracking of induced pluripotent stem cell-derived cardiomyocytes
John W. Ostrominski, Ravi Chandra Yada, Noriko Sato, Michael Klein, Ksenia Blinova, Dakshesh Patel, Racquel R. Valadez, Maryknoll Palisoc, Stefania Pittaluga, Kah Whye...> ;Stem Cells Translational Medicine. 2020 Oct 1
Join now to see all

Press Mentions

Semaglutide Works Across LVEF Range: STEP-HFpEF AnalysisOctober 12th, 2023
STEP-HFpEF: Similar Improvements with Semaglutide Across LVEF Categories in Patients with HFpEF and ObesityOctober 18th, 2023
Prevalence of Cardiorenal Metabolic Diseases in the United StatesNovember 8th, 2023
Join now to see all